Cited by 70Retinal Development and DisordersRetinal Diseases and TreatmentsRetinoids in leukemia and cellular processes

Insights into the Molecular Properties of ABCA4 and Its Role in the Visual Cycle and Stargardt Disease

Molday, Robert S.·2015·Progress in Molecular Biology and Translational Science

Abstract

ABCA4 is a member of the A-subfamily of ATP-binding cassette (ABC) transporters localized in rod and cone outer segment disc membranes. Over 800 mutations in ABCA4 are now known to cause Stargardt macular degeneration and related retinal degenerative diseases. Biochemical studies have shown that ABCA4 transports or flips the 11-cis and all-trans isomers of N-retinylidene-phosphatidylethanolamine across disc membranes, thereby facilitating the removal of retinal from disc membranes through the visual cycle and preventing the accumulation of potentially toxic bisretinoid compounds in photoreceptor and retinal pigment epithelial cells. This chapter summarizes studies which have led to our understanding of the role of ABCA4 in the visual cycle and Stargardt disease.

Integrity signals

Registry

Crossref · 10.1016/bs.pmbts.2015.06.008

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the membranes of outer photoreceptor segments, nonenzymatically formed toxic bisretinoids are converted upon phagocytosis in the acidic environment of RPE phagolysosomes to bisretinoid pyridinium compound A2E and related bisretinoids.

    “In the membranes of outer photoreceptor segments are nonenzymatically formed toxic bisretinoids. Upon phagocytosis, these bisretinoids are in the acidic environment of RPE phagolysosomes converted to bisretinoid pyridinium compound A2E and related bisretinoids [54,69,70,71,72,73,74].”

    From The Role of Vitamin A in Retinal Diseases (2022) · cites this paper as [71]

  • A2E is insoluble, tends to aggregate, and accumulates as lipofuscin deposits in RPE cells, compromising RPE function and leading to cell death.

    “The latter are insoluble, have a tendency to aggregate and accumulate as lipofuscin deposits in the RPE cells, compromising RPE function and leading to cell death.”

    From The Role of Vitamin A in Retinal Diseases (2022) · cites this paper as [71]

  • ABCA4 protein is a 250 kDa flippase that transports all-trans-retinal across the photoreceptor membrane to the cytoplasmic side, making it an important part of the visual cycle and removal of toxic vitamin A products.

    “ABCA4 protein is a 250 kDa flippase, which transports all-trans-retinal, across the photoreceptor membrane to the cytoplasmic side, making it an important part of the visual cycle and removal of toxic vitamin A products [71,92].”

    From The Role of Vitamin A in Retinal Diseases (2022) · cites this paper as [71]

  • Trapped vitamin A derivatives and toxic compounds can react nonenzymatically to form toxic bisretinoids.

    “Trapped vitamin A derivatives and toxic compounds can react nonenzymatically, leading to the formation of toxic bisretinoids.”

    From The Role of Vitamin A in Retinal Diseases (2022) · cites this paper as [71]

  • ABCA4 dysfunction leads to the accumulation of vitamin A derivatives and toxic compounds in photoreceptor outer segments because they cannot be efficiently removed.

    “ABCA4 dysfunction leads to the accumulation of vitamin A derivatives and toxic compounds, as they cannot be efficiently removed from the photoreceptor outer segment.”

    From The Role of Vitamin A in Retinal Diseases (2022) · cites this paper as [71]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Molday, R. S.
Affiliations
University of British Columbia (CA)
Corresponding author
Molday, Robert S.
Venue
Progress in Molecular Biology and Translational Science
Publisher
Elsevier
Published
2015
Volume
134
Pages
415-431
ISSN
1877-1173 (ISSN-L)
OpenAlex
W2414872275
Cited by
70
References
12
Citations by year
2026: 4 · 2025: 3 · 2024: 8 · 2023: 3 · 2022: 4 · 2021: 14 · 2020: 12 · 2019: 11 · 2018: 4 · 2017: 4 · 2016: 3
FWCI
5.85
Type
book chapter
Language
en
Open access
closed
Locations
  • Progress in molecular biology and translational science (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • Canadian Institutes of Health Research (106667_1)
  • National Eye Institute (EY002422, R01EY002422)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
ABCA4, ABC transporters, visual cycle, Stargardt disease, photoreceptors, retinal pigment epithelium, retinal degeneration, ABCA4 mutations
MeSH terms
Stargardt Disease, Multigene Family, Humans, Macular Degeneration, Models, Biological, Phosphatidylethanolamines, Retinoids, Visual Pathways, ATP-Binding Cassette Transporters

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review